作者: Caroline Bodet-Milin , Cyrille Touzeau , Christophe Leux , Mehmet Sahin , Anne Moreau
DOI: 10.1007/S00259-010-1469-2
关键词:
摘要: Purpose 18F-fluorodeoxyglucose (FDG) PET is a non-invasive imaging technique recommended for the management of both diffuse large B-cell and Hodgkin’s lymphomas. This retrospective study investigated value FDG initial staging its prognostic impact on patients with mantle cell lymphoma (MCL).